Tapering approach: Reduce by 25-50% every 2-3 months while tracking weight stability
Finally, be aware that injection site reactions such as redness, swelling, or pain are possible
Supporting Evidence: Any supporting medical literature or studies that back up the need for the treatment can be mentioned
Alternatively, they were provided with a Dexcom G6 device for the purpose of continuous glucose monitoring [2]
As the efficacy of these medications increases, the role of the provider must shift from simply prescribing a drug to managing the nuanced intersection of high-dose pharmacology and essential lifestyle support
Rarely, SGLT2 inhibitors have been associated with diabetic ketoacidosis (DKA), even with near-normal blood glucose levels (euglycaemic DKA)